Skip to main content

ADHD

ADHD
The US Food and Drug Administration has accepted the filing of a New Drug Application for an investigational amphetamine for the treatment of attention-deficit/hyperactivity disorder specifically designed to resist manipulation.
ADHD
Children who meet a greater number of recommendations for a healthy lifestyle at age 10 or 11 are less likely to receive a diagnosis of attention-deficit/hyperactivity disorder by age 14, a published study suggests.
ADHD
Neurofeedback treatments for attention-deficit/hyperactivity disorder (ADHD) demonstrate medium to large effect sizes and remission rates between 32% and 47%, according to a published study.
ADHD
A digital therapeutic intervention delivered through a video game-like interface shows promise in improving attention in children with attention deficit/hyperactivity disorder (ADHD), according to a study in The Lancet Digital Health.
ADHD
As children diagnosed with attention-deficit/hyperactivity disorder transition into adolescence and young adulthood, primary care providers are missing the mark in monitoring them for several important health risks, a study warns.
ADHD
In adults with attention-deficit/hyperactivity disorder (ADHD), reductions in ADHD-Rating Scale-IV total score (ADHD-RS-IV-TS) were significantly greater with SHP465 mixed amphetamine salts (MAS) extended-release than placebo. These post hoc…
ADHD
Purpose: Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) designed to provide treatment effect in the early morning, throughout the day, and into the evening. Herein, we present the efficacy and safety of DR…
ADHD
Purpose: Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) designed to provide treatment effect in the early morning, throughout the day, and into the evening. This pivotal, phase 3, forced-dose titration…
ADHD
Purpose: Sleep disturbances are associated with attention-deficit/hyperactivity disorder (ADHD) and methylphenidate (MPH) treatment. We assessed whether sleep-related adverse event (AE) rates are affected by sample and study design features of…
ADHD
Adult attention-deficit/hyperactivity disorder (ADHD) can affect work productivity. This survey examined relationships between oral stimulant medication adherence, work productivity and related indirect costs, and ADHD symptom level among US adults…
ADHD
Adult attention-deficit/hyperactivity disorder (ADHD) is associated with impaired executive function (EF). This post hoc analysis examines relationships between changes in ADHD symptoms and EF, as measured by the ADHD-Rating Scale-IV (ADHD-RS-IV)…
Back to Top